FDA top drugs official Pazdur retiring shortly after starting – report
Less than a month after taking the role, Richard Pazdur, the director of the US FDA's Center for Drug Evaluation and...
Tag: LLY
Market Voices: Trump on Fed chair, US-UK pharma deal, Lilly’s Zepbound
Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks....
UK to pay 25% more for new drugs under deal with US
An agreement in principle reached between UK and US trade negotiators will have the latter's National Health Service pay 25%...
Eli Lilly lowers starting dose costs for Zepbound on direct purchase platform
Eli Lilly (LLY) is cutting prices for starting doses of Zepbound single-dose vials on its LillyDirect direct-to-consumer...
Trump admin negotiates 71% discount on Ozempic, Wegovy for Medicare patients
The Trump administration negotiated lower prices on 15 costly drugs under Medicare, including Ozempic and Wegovy. The...
US, UK nearing drug prices deal – report
The US and UK governments are said to be close to a deal that would boost prices of prescription drugs in the UK in...
Can Novo unravel Lilly rally with Alzheimer’s data for GLP-1
Lilly’s (LLY) recent climb to reach a $1T market cap will come under scrutiny in the coming days when Novo Nordisk (NVO)...
White House at odds with FDA Commissioner Makary top aide – report
FDA Commissioner Marty Makary is said to be pushing back at an effort from the White House to remove one of his top aides....
LLY joins $1T club but doesn’t feature in SA’s top 10 large-cap healthcare stocks
Eli Lilly (LLY) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth...
Lilly market cap exceeds $1T in a first for healthcare
Eli Lilly (LLY) shares rose 1.7% shortly after the market opened on Friday to exceed the $1T market capitalization,...